1-4 of 4
Jaroslav Jelinek, M.D., Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hypomethylation Induction and Molecular Response after Decitabine Therapy in Chronic Myelomonocytic Leukemia (CMML).

Yasuhiro Oki, MD, Jaroslav Jelinek, M.D. Ph.D., Hagop M. Kantarjian, M.D., Jean-Pierre J. Issa, M.D.
Journal: Blood
Blood (2006) 108 (11): 2322.
https://doi.org/10.1182/blood.V108.11.2322.2322
Published: 2006
Journal Articles

Epigenetic Suppression of the CTNNA1 Gene, Encoding the α-Catenin Protein, which Is Located in the 5q31 Critical Deleted Region in Malignant Myeloid Disorders with del(5q).

Ting Xi Liu, M.D., Ph.D., Michael Becker, M.D., Karl Hsu, M.D., Jaroslav Jelinek, M.D., Ph.D., Min Deng, M.D., Clara Bloomfield, M.D.4, Jean-Pierre Issa, M.D., Michael F. Clarke, M.D., A. Thomas Look, M.D.4
Journal: Blood
Blood (2004) 104 (11): 203.
https://doi.org/10.1182/blood.V104.11.203.203
Published: 2004
Journal Articles

Hypomethylation Dynamics Following Decitabine Therapy in Chronic Myelogenous Leukemia.

Jean-Pierre J. Issa, M.D., Vazganush Gharibyan, Ph.D., Jaroslav Jelinek, M.D., Ph.D., Gail Morris, RN, Srdan Verstovsek, M.D., Moshe Talpaz, M.D., Guillermo Garcia-Manero, M.D., Hagop M. Kantarjian, M.D.
Journal: Blood
Blood (2004) 104 (11): 2956.
https://doi.org/10.1182/blood.V104.11.2956.2956
Published: 2004
Journal Articles

Identification of 41 Novel Promoter-Associated CpG Islands Methylated in Leukemias.

Jaroslav Jelinek, M.D., Ph.D., Rajan Mannari, M.D., Jean-Pierre Issa, M.D.
Journal: Blood
Blood (2004) 104 (11): 1126.
https://doi.org/10.1182/blood.V104.11.1126.1126
Published: 2004